Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response (Q44237462)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 July 2012
edit
Language Label Description Also known as
English
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
scientific article published on 11 July 2012

    Statements

    Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response (English)
    David N Taylor
    John J Treanor
    Casey Johnson
    Scott Umlauf
    Langzhou Song
    Uma Kavita
    Lynda Tussey
    Karen Ozer
    Thomas Hofstaetter
    Alan Shaw
    11 July 2012
    5761-5769

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit